Data / Form D filings / Circle Biologics, Inc.
Circle Biologics, Inc.: Form D filings
Circle Biologics, Inc., a biotechnology company in Minneapolis, MN, filed 4 Form D notices with the SEC in 2012. The latest, on October 25, 2012, reports $616,666 sold of a $1.5 million offering to 5 investors.
Find out what Circle Biologics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3650 ANNAPOLIS LANE, SUITE 105, Minneapolis, MN, 55447
- Phone
- (763) 577-0900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1543622
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2012 | Amendment | $1,500,000 | $616,666 | $883,334 | 5 | Jul 20, 2012 | sec.gov |
| Sep 19, 2012 | Amendment | $1,500,000 | $466,666 | $1,033,334 | 4 | Jul 20, 2012 | sec.gov |
| Aug 20, 2012 | New notice | $1,500,000 | $300,000 | $1,200,000 | 3 | Jul 20, 2012 | sec.gov |
| Aug 9, 2012 | New notice | $100,000 | $100,000 | $0 | 1 | Jul 27, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| FRED F. KOLB | Director | |
| ELIZABETH F. COULL | Director | |
| MATTHEW KYLE | Executive Officer | |
| RICHARD F. KYLE, M.D. | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Oct 22, 2012 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Circle Biologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.